CD8+ T cells’ infiltration in metastatic melanoma may be stimulated by the administration of B1 receptor agonist des-Arg9-bradykinin (DABK), considering the involvement of stromal bradykinin signalling and melanoma cells bradykinin receptors in the tumour microenvironment [139,140]. The gene discussed is CD8A; the disease is melanoma.